Briefly Bio

Briefly Bio has developed software to improve reproducibility in scientific research. Their AI-powered platform helps scientists capture and share their experimental work clearly and consistently, addressing the significant issue of reproducibility in biological experiments and improving collaboration. This shared language for experiments facilitates better understanding and builds upon existing work.

Buy Funded Startups lists

Funding Round: Pre-Seed

Funding Amount: $1.2M

Date: 17-Jul-2024

Investors: Compound VC, NP Hard, Tiny VC, angel investors across tech and biotech

Markets: Biotechnology, AI, Pharmaceutical

HQ: Ladbroke Grove, London, England, United Kingdom

Founded: 2022

Website: https://briefly.bio/

LinkedIn: https://www.linkedin.com/company/briefly-bio

Twitter: https://twitter.com/brieflybio

Instagram: